Literature DB >> 7553684

Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.

H Sakahara1, H Onodera, M Shirato, Z Yao, G Ohshio, H Kobayashi, M Hosono, S Yano, H Nakada, M Imamura.   

Abstract

A murine monoclonal antibody MLS102 recognizes sialosyl-Tn antigen in mucin and immunohistochemically reacts with more than 80% of colorectal cancer tissues. The purpose of this study was to assess the usefulness of this monoclonal antibody for the immunoscintigraphy of colorectal cancer. Planar and SPECT images were obtained on day 2 or day 3 after injection of 2 mg and 74 MBq 111In-labeled MLS102 antibody into 17 patients with colorectal cancer. Nine of 11 primary tumors and 4 of 6 locally recurrent tumors were detected. Positive images were obtained in all tumors larger than 4.5 x 2.7 cm. Three tumors of less than 2.5 cm and 1 recurrent tumor, which was missed by other imaging modalities, were negative. There were no adverse reactions. Human anti-(mouse Ig) antibody developed in 4 patients. Although improvement of detectability for smaller tumors needs to be pursued, the antibody MLS102 is potentially promising for use in immunoscintigraphy of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553684     DOI: 10.1007/bf01521341

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.

Authors:  S V Deshpande; R Subramanian; M J McCall; S J DeNardo; G L DeNardo; C F Meares
Journal:  J Nucl Med       Date:  1990-02       Impact factor: 10.057

2.  Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against alpha-fetoprotein.

Authors:  H Sakahara; K Endo; T Nakashima; M Koizumi; H Ohta; K Torizuka; T Furukawa; Y Ohmomo; A Yokoyama; K Okada
Journal:  J Nucl Med       Date:  1985-07       Impact factor: 10.057

3.  Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.

Authors:  J L Murray; M G Rosenblum; L Lamki; H J Glenn; Z Krizan; E M Hersh; C E Plager; R M Bartholomew; M W Unger; D J Carlo
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

4.  Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

Authors:  B D Collier; H Abdel-Nabi; R J Doerr; S J Harwood; J Olsen; E H Kaplan; G G Winzelberg; S J Grossman; D N Krag; E P Mitchell
Journal:  Radiology       Date:  1992-10       Impact factor: 11.105

5.  Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.

Authors:  L M Lamki; Y Z Patt; M G Rosenblum; L J Shanken; L B Thompson; S A Schweighardt; J M Frincke; J L Murray
Journal:  Radiology       Date:  1990-01       Impact factor: 11.105

6.  Reduced bone marrow uptake of indium-111 labelled monoclonal antibody after radiotherapy.

Authors:  H Sakahara; H Onodera; H Kobayashi; Z Yao; I Yamashina; J Konishi
Journal:  Eur J Nucl Med       Date:  1994-11

7.  Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.

Authors:  H Sakahara; K Endo; T Nakashima; M Koizumi; M Kunimatsu; Y Kawamura; H Ohta; T Nakamura; H Tanaka; Y Kotoura
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

8.  Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody.

Authors:  J D Beatty; R B Duda; L E Williams; K Sheibani; R J Paxton; B G Beatty; V J Philben; J L Werner; J E Shively; W G Vlahos
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

9.  A monoclonal antibody that recognizes a cluster of a disaccharide, NeuAc alpha(2----6)GalNAc, in mucin-type glycoproteins.

Authors:  A Kurosaka; H Kitagawa; S Fukui; Y Numata; H Nakada; I Funakoshi; T Kawasaki; T Ogawa; H Iijima; I Yamashina
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

10.  Intratumor localization of monoclonal antibody in patients with melanoma treated with antibody to a 250,000-dalton melanoma-associated antigen.

Authors:  R W Schroff; C S Woodhouse; K A Foon; R K Oldham; M M Farrell; R A Klein; A C Morgan
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

View more
  2 in total

1.  Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody.

Authors:  H Sakahara; M Hosono; H Kobayashi; Z Yao; T Saga; S Yano; K Endo; T Mori; J Konishi
Journal:  Jpn J Cancer Res       Date:  1996-06

2.  Anti-murine antibody response to mouse monoclonal antibodies in cancer patients.

Authors:  H Sakahara; T Saga; H Onodera; Z Yao; Y Nakamoto; M Zhang; N Sato; H Nakada; I Yamashina; K Endo; J Konishi
Journal:  Jpn J Cancer Res       Date:  1997-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.